Presentation TVT 2013 Pharmacotherapy Alternatives During and After TAVR: Is There an Optimal Regimen? Presenter: Corrado Tamburino June 12, 2013
Presentation TVT 2013 An Anticoagulated Patient with Severe Paravalvular Regurgitation and Ostial Left Main Disease Presenter: Peter Pollak June 12, 2013
Presentation TVT 2013 Baseline Frailty Status of the "Extreme Risk" Patients in the US CoreValve Trial Presenter: Jeffrey Popma June 12, 2013
Presentation TVT 2013 The "Essential Primer" on Surgical Risk Scores: Key Take-home Messages Presenter: Todd Dewey June 12, 2013
Presentation TVT 2013 Early Clinical Experiences with the Apica TA-TAVR System Presenter: Joerg Kempfert June 12, 2013
Presentation TVT 2013 Taking Strokes Seriously: Definitions (VARC 2), Stroke Grading Scores, Study Endpoints, Neuroimaging, and Neurocognitive Function Presenter: Martin Leon June 12, 2013
Presentation TVT 2013 New Sheath Technologies for Transfemoral Access: Advantages and Limitations Presenter: Vasilis Babaliaros June 12, 2013
Presentation TVT 2013 An Artificial Construct Doomed to Extinction Presenter: Ganesh Manoharan June 12, 2013
Presentation TVT 2013 Paravalvular Leak Closure For Persisting Aortic Regurgitation after implantation of the CoreValve Transcatheter Valve Presenter: Petra Poliacikova June 12, 2013